Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.
Clinical trial NCT00315458 · TERMINATED
Trial details
- NCT number
- NCT00315458
- Sponsor
- Purdue Pharma LP
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2005-03-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.